0001596783-24-000043.txt : 20240710 0001596783-24-000043.hdr.sgml : 20240710 20240710165620 ACCESSION NUMBER: 0001596783-24-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240708 FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Masanovich Matti CENTRAL INDEX KEY: 0001359151 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 241110452 MAIL ADDRESS: STREET 1: COLLINS & AIKMAN CORPORATION STREET 2: 250 STEPHENSON HIGHWAY CITY: TROY STATE: MI ZIP: 48083 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wk-form4_1720644973.xml FORM 4 X0508 4 2024-07-08 0 0001596783 Catalent, Inc. CTLT 0001359151 Masanovich Matti C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 SVP, Chief Financial Officer 0 Common Stock 2024-07-08 4 S 0 2993 56.74 D 33871 D Shares sold by the reporting person through an automatic sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the omnibus incentive plan of the Issuer. No shares were withheld by or surrendered to the Issuer. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $56.69 to $56.785, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes restricted stock units. /s/ Joseph A. Ferraro, attorney-in-fact 2024-07-10 EX-24 2 mmpoa.txt EX-24 POWER OF ATTORNEY Know all by these presents that the undersigned does hereby make, constitute, and appoint each of Mansi Parikh and Joseph Ferraro, or either of them, as a true and lawful attorney-in-fact of the undersigned, with full powers of substitution and revocation, for and in the name, place, and stead of the undersigned (in the undersigned's individual capacity) to execute and deliver such forms that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Catalent, Inc. (i) pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended ("Section 16"), including without limitation statements on Form 3, Form 4, and Form 5, and any amendments thereto; and (ii) in connection with any applications for EDGAR access codes, including without limitation the Form ID. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to make filings pursuant to Section 16 with regard to the undersigned's ownership of or transactions in securities of Catalent, Inc., unless earlier revoked in writing. The undersigned acknowledges that Mansi Parikh and Joseph Ferraro are not assuming any of the undersigned's responsibilities to comply with Section 16. /s/ Matti Masanovich ---------------------------------- Matti Masanovich Date: July 10, 2024